Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 157.49
- Piotroski Score 2.00
- Grade N/A
- Symbol (TELO)
- Company Telomir Pharmaceuticals, Inc. Common Stock
- Price $5.91
- Changes Percentage (-0.51%)
- Change -$0.03
- Day Low $5.75
- Day High $5.99
- Year High $20.72
Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells. It develops TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic intervention against age-related inflammatory conditions, such as hemochromatosis and osteoarthritis, as well as for post-chemotherapy recovery by interrupting and preventing the interleukin-17 induced inflammatory pathways. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. on October 10, 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Baltimore, Maryland.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) N/A
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.00
- Trailing P/E Ratio N/A
- Forward P/E Ratio N/A
- P/E Growth N/A
- Net Income $-13,071,864
Income Statement
Quarterly
Annual
Latest News of TELO
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Q&A: Zedd waited nine years to release a new album. He says the kaleidoscopic 'Telos' is 'timeless'
Grammy-winning producer and DJ Zedd has finally released his long-awaited third album, "Telos," after almost a decade. The album is a highly collaborative project, featuring artists like Muse, John Ma...
By AP NEWS | 2 weeks ago -
We're Not Very Worried About Telos' (NASDAQ:TLS) Cash Burn Rate
Even if a company is not profitable, its stock may still perform well. Telos (NASDAQ:TLS) had $94m cash and 7.0 years cash runway in 2024, despite $13m cash burn....
By Yahoo! Finance | 1 month ago -
Telomeres, Or How Your DNA Shrinks Over Time
Telomeres, protective caps at chromosome ends, are vital for cell division and aging. Shortened telomeres indicate aging and disease risk. Lifestyle choices like diet, exercise, stress management, and...
By Forbes | 1 month ago
